Form SC 13G/A NEVRO CORP Filed by: BlackRock Inc.

Go back to Form SC 13G/A NEVRO CORP Filed by: BlackRock Inc.

Citi Moves to Sidelines Nevro Corp (NVRO), Moves to Neutral, 'uncertainty remains high'

August 8, 2024 4:41 PM EDT

Citi analyst Joanna Wuensch upgraded Nevro Corp (NYSE: NVRO) from Sell to Neutral with a price target of $6.89.

The analyst comments "With the 2Q24 print (link), we are upgrading NVRO to Neutral from Sell. While the quarter itself was fairly benign, the... More